Phase I and Pharmacokinetic Study of ABI-007, Albumin-bound Paclitaxel, Administered Every 3 Weeks in Japanese Patients with Solid Tumors

Por Yamada, Kazuhiko, Yamamoto, Noboru, Yamada, Yasuhide, Mukohara, Toru, Minami, Hironobu, Tamura, Tomohide
Publicado em 2010

Phase I and Pharmacokinetic Study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese Patients with Solid Tumors

Por Yamamoto, Noboru, Yamada, Yasuhide, Fujiwara, Yutaka, Yamada, Kazuhiko, Fujisaka, Yasuhito, Shimizu, Toshio, Tamura, Tomohide
Publicado em 2009

Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid tumors

Por Murakami, Haruyasu, Ueda, Yutaka, Shimoyama, Tatsu, Yamamoto, Noboru, Yamada, Yasuhide, Arioka, Hitoshi, Tamura, Tomohide
Publicado em 2010

Phase I and pharmacokinetic study of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, by twice daily oral administration between meals in patients with advanced solid t...

Por Ueda, Yutaka, Shimoyama, Tatsu, Murakami, Haruyasu, Yamamoto, Noboru, Yamada, Yasuhide, Arioka, Hitoshi, Tamura, Tomohide
Publicado em 2010

Phase 1 and dose-finding study of patritumab (U3-1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors

Por Wakui, Hiroshi, Yamamoto, Noboru, Nakamichi, Shinji, Tamura, Yousuke, Nokihara, Hiroshi, Yamada, Yasuhide, Tamura, Tomohide
Publicado em 2014

Alveolar Soft Part Sarcoma: A Single-Center 26-Patient Case Series and Review of the Literature

Por Ogura, Koichi, Beppu, Yasuo, Chuman, Hirokazu, Yoshida, Akihiko, Yamamoto, Noboru, Sumi, Minako, Kawano, Hirotaka, Kawai, Akira
Publicado em 2012

A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cells

Por Yamashita, Makiko, Kitano, Shigehisa, Aikawa, Hiroaki, Kuchiba, Aya, Hayashi, Mitsuhiro, Yamamoto, Noboru, Tamura, Kenji, Hamada, Akinobu
Publicado no Sci Rep (2016)

Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors

Por Mizugaki, Hidenori, Yamamoto, Noboru, Murakami, Haruyasu, Kenmotsu, Hirotsugu, Fujiwara, Yutaka, Ishida, Yoshimasa, Kawakami, Tomohisa, Takahashi, Toshiaki
Publicado no Invest New Drugs (2016)

Randomized phase II study of sequential carboplatin plus paclitaxel and gefitinib in chemotherapy-naïve patients with advanced or metastatic non-small-cell lung cancer: Long-term f...

Por Kubo, Emi, Yamamoto, Noboru, Nokihara, Hiroshi, Fujiwara, Yutaka, Horinouchi, Hidehito, Kanda, Shintaro, Goto, Yasushi, Ohe, Yuichiro
Publicado no Mol Clin Oncol (2017)

Antibody-catalyzed anaerobic destruction of methamphetamine

Por Xu, Yang, Hixon, Mark S., Yamamoto, Noboru, McAllister, Laura A., Wentworth, Anita D., Wentworth, Paul, Janda, Kim D.
Publicado em 2007

A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors

Por Nokihara, Hiroshi, Yamamoto, Noboru, Yamada, Yasuhide, Yamada, Kazuhiko, Hirata, Taizo, Goto, Yasushi, Tanioka, Maki, Ikeda, Yoko, Tamura, Tomohide
Publicado em 2012

Effect of mental practice using inverse video of the unaffected upper limb in a subject with chronic hemiparesis after stroke

Por Iso, Naoki, Ooso, Shirou, Yamamoto, Noboru, Moriuchi, Takefumi, Sagari, Akira, Iso, Fumiko, Tanaka, Koji, Tabira, Takayuki, Higashi, Toshio
Publicado no J Phys Ther Sci (2016)

Pharmacodynamic change in plasma angiogenic proteins: a dose-escalation phase 1 study of the multi-kinase inhibitor lenvatinib

Por Koyama, Noriyuki, Saito, Kenichi, Nishioka, Yuki, Yusa, Wataru, Yamamoto, Noboru, Yamada, Yasuhide, Nokihara, Hiroshi, Koizumi, Fumiaki, Nishio, Kazuto, Tamura, Tomohide
Publicado no BMC Cancer (2014)

Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors

Por Yamamoto, Noboru, Nokihara, Hiroshi, Yamada, Yasuhide, Shibata, Takashi, Tamura, Yosuke, Seki, Yoshitaka, Honda, Kazunori, Tanabe, Yuko, Wakui, Hiroshi, Tamura, Tomohide
Publicado no Invest New Drugs (2016)

A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors

Por Nakamichi, Shinji, Nokihara, Hiroshi, Yamamoto, Noboru, Yamada, Yasuhide, Honda, Kazunori, Tamura, Yosuke, Wakui, Hiroshi, Sasaki, Tatsuya, Yusa, Wataru, Fujino, Katsuki, Tamura, Tomohide
Publicado no Cancer Chemother Pharmacol (2015)

Comprehensive screening of target molecules by next-generation sequencing in patients with malignant solid tumors: guiding entry into phase I clinical trials

Por Tanabe, Yuko, Ichikawa, Hitoshi, Kohno, Takashi, Yoshida, Hiroshi, Kubo, Takashi, Kato, Mamoru, Iwasa, Satoru, Ochiai, Atsushi, Yamamoto, Noboru, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado no Mol Cancer (2016)

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy

Por Nakamura, Yoshio, Kitano, Shigehisa, Takahashi, Akira, Tsutsumida, Arata, Namikawa, Kenjiro, Tanese, Keiji, Abe, Takayuki, Funakoshi, Takeru, Yamamoto, Noboru, Amagai, Masayuki, Yamazaki, Naoya
Publicado no Oncotarget (2016)

Phase I study for ridaforolimus, an oral mTOR inhibitor, in Japanese patients with advanced solid tumors

Por Seki, Yoshitaka, Yamamoto, Noboru, Tamura, Yosuke, Goto, Yasushi, Shibata, Takashi, Tanioka, Maki, Asahina, Hajime, Nokihara, Hiroshi, Yamada, Yasuhide, Shimamoto, Takashi, Noguchi, Kazuo, Tamura, Tomohide
Publicado em 2011

Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma

Por Tamura, Yosuke, Fujiwara, Yutaka, Yamamoto, Noboru, Nokihara, Hiroshi, Horinouchi, Hidehito, Kanda, Shintaro, Goto, Yasushi, Kubo, Emi, Kitahara, Shinsuke, Tsuruoka, Kenjiro, Tsuta, Koji, Ohe, Yuichiro
Publicado no BMC Res Notes (2015)

Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism

Por Fujiwara, Yutaka, Hamada, Akinobu, Mizugaki, Hidenori, Aikawa, Hiroaki, Hata, Toshiyuki, Horinouchi, Hidehito, Kanda, Shintaro, Goto, Yasushi, Itahashi, Kota, Nokihara, Hiroshi, Yamamoto, Noboru, Ohe, Yuichiro
Publicado no Cancer Sci (2016)